Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 13 clinical trials
Dopamine Effect on Inhibitory Control (DEI)

The effect of Levodopa medication on inhibitory control in Parkinson's patients is extremely debated despite the fact that this has potential clinical and therapeutic implications. A key confounding factor of many previous studies is that they did not take the disease duration in consideration. In fact, in moderate-to-advanced stages of …

dyskinesia
dopamine
dopamine agonists
levodopa
dopa
  • 0 views
  • 02 Jun, 2022
  • 1 location
Clinical Features Associated With Restless Legs Syndrome.

, daytime sleepiness, depression and decreased quality of life. Dopamine agonists, alpha-2-delta ligands and opiates are key medications for RLS. The natural course of RLS is very heterogeneous with a risk

dopamine
dopamine agonists
  • 57 views
  • 29 Sep, 2021
  • 1 location
Vigor and the LDR in Parkinson Disease

Parkinson disease (PD) is a common disorder in which reduced speed of movement results from inadequate brain production of the chemical dopamine. The most effective treatment for PD is the drug levo-dopa, which partially replaces brain dopamine. Despite decades of successful use, how levo-dopa improves speed of movement in PD …

dopamine
carbidopa/levodopa
tremor
sinemet
carbidopa
  • 0 views
  • 25 Jan, 2022
  • 1 location